Bayern Kapital — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
mbiomics designs and develops complex Live Biotherapeutic Products (LBPs) based on gut microbiome consortia to treat severe and chronic diseases, with a pipeline spanning oncology (melanoma, NSCLC/renal cell carcinoma), IBD, and ASD.
AI & Machine LearningBiotechHealthtech
HealthtechNew Orleans, US
Mark Heiman(Executive Officer)Dale Pfost(Executive Officer, Director, Promoter)
BoardDon Marvin(Director)Richard Montgomery(Director)Ross Barrett(Director)John Elstrott(Director, Promoter)
Co-investorsSofinnova VenturesDCVC (Data Collective)FemHealth VenturesPangaea Ventures
Proxima develops stellarator fusion power plants designed to deliver clean, grid-ready electricity.
CleantechDeep TechEnergyMunich, DE
Dr. Francesco Sciortino(CEO and co-founder)Dr. Lucio Milanese(Co-founder and Chief External Affairs Officer)Dr. Jorrit Lion(Chief Scientist and co-founder)Martin Kubie(Chief Engineer and co-founder)inJonathan Schilling(Head of Labs and co-founder)in
Co-investorsBalderton CapitalBurda Principal InvestmentsCherry VenturesDeepTech & Climate FondsElaiaLeitmotif+8 more
Thermal is a surf travel company that connects surfers with local guides and curated trips to over 20 destinations worldwide, offering access to premium surf experiences and cultural immersion.
B2B MarketplacesConsumerTravel & HospitalityMelbourne, AU
Glen Gaudion(CEO)
Co-investorsAlleyCorpAlley Robotics VenturesAxeleo CapitalOld College CapitalScottish Enterprise
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.